Travel brand Cox & Kings returns under the ownership of PE firm Wilson & Hughes Pte
The Hindu
Wilson & Hughes PTE acquires Cox & Kings, aiming to revolutionize travel with advanced technology and tailored experiences.
Cox & Kings, one of the oldest travel brands has re-entered into the travel market under Wilson & Hughes Pte, a Singapore-based private equity and venture capital firm.
The brand’s erstwhile owners Cox & Kings Ltd which was declared bankrupt 2020 was subsequently liquidated through the Insolvency & Bankruptcy Code (IBC) procedure.
Acquired through its Indian subsidiary, Wilson & Hughes PTE, has exclusively acquired the brand Cox & Kings along with over 200 plus specialised sub-brands that were part of its portfolio. The company has not disclosed the cost of acquisition.
Wilson & Hughes is planning to reshape the way people live, travel, and experience the world through the acquisition of this brand.
The focus is on integrating advanced technology—AI, machine learning, and data analytics—to offer travellers tailor-made journeys that anticipate their needs and elevate the traditional travel experience, the company said.
“The travel industry is evolving rapidly, and we recognize the tremendous opportunity to redefine global travel experiences,” said Karan Agarwal, Director, Wilson & Hughes.
“Our goal is to merge the best of tradition with forward-thinking technology. Our objective extends beyond enhancing travel; it’s about reinforcing the trusted legacy that has positioned Cox & Kings as a cornerstone of the industry for generations,” he added.
Equity markets decline on weak earnings, global trends; inflation hits 14-month high, foreign funds exit, oil prices rise.
Swiggy IPO debuts with a 7.69% jump at NSE, market valuation at ₹89,549.08 crore; shares listed at ₹412 on BSE.
Shares in Samsung Electronics fell on Wednesday to their lowest level in more than four years.
Mercedes-Benz India introduces the new Mercedes-AMG C 63 S E Performance sportscar with hybrid powertrain and innovative business model.
Hyundai Motor India Ltd. reports 16% profit decline in Q3 due to market sentiments, geopolitical factors, and Red Sea crisis.
Equity market plunges over 800 points, eroding market capitalisation by ₹5.29 lakh crore amid global economic concerns.
Aurobindo Pharma's CuraTeQ Biologics receives EMA GMP certificate for biosimilars, paving way for European approvals of three products.
BCCI to withdraw insolvency plea against Byju's after Supreme Court sets aside NCLAT judgement, NCLT hearing scheduled.
Natco Pharma's Q2 profits soar 83% to ₹676.5 crore, driven by robust exports and stable domestic business.
India's industrial output rebounds with 3.1% growth in September, led by manufacturing, despite weak electricity and mining sectors.
India's retail inflation hits 6.2% in October, driven by a 10.9% spike in food prices, breaching RBI's upper limit.